Laboratory StudyElevation of neuron-specific enolase and S-100β protein level in experimental acute spinal cord injury
Introduction
Traumatic spinal cord injury (SCI) often results in complete or partial motor and sensory neurological deficits under the level of the injury. Much effort has been expended in attempts to evaluate SCI severity and subsequent recovery potential. But there is still no consensus on which clinical diagnostic tests could be applied to reliably indicate the subclinical neurophysiological changes occuring in the spinal cord during the acute phase, and this presents a major obstacle in predicting the progression of cell death as well as tissue destruction in SCI cases. Recently, there has been growing interest in serum biomarkers as indicators of tissue destruction in central nervous system (CNS) diseases. Several previous studies have indicated that monitoring the levels of neuron- or astroglia-specific proteins in the serum and cerebrospinal fluid (CSF) might turn out to be a useful approach for evaluating the severity of CNS injury (e.g. traumatic brain injury, cerebral infraction, intracranial hemorrhage, and SCI). The aim of this study was to ascertain the relationship between protein levels of neuron-specific enolase (NSE) and S-100β in serum and CSF and the severity of acute SCI in an animal model.
Section snippets
Experimental animals and grouping
We used 80 adult male Sprague-Dawley rats weighing 200 ± 20 g (provided by the Experimental Animal Center of Zhejiang University School of Medicine) for this study. Rats were randomly divided into four groups: control group, mild SCI group, moderate SCI group and severe SCI group (20 rats per group).
SCI model induction
Rats were anesthetized with 1% sodium pentobarbital (40 mg/kg intraperitoneally). After dorsal laminectomy of the T8 and T9 vertebrae to expose the spinal cord, 60 rats (the mild, moderate and severe
Neurological scoring
There were significant differences between the SCI group and the control group with respect to neurological score as determined using the modified Tarlov method and CBS (p < 0.05). A higher SCI injury grade correlated with poorer neurological score (p < 0.05) (Table 1).
NSE level
Over the course of the experiment, changes in the serum NSE protein level were similar to those that occurred in the CSF. In the control group, the NSE level remained low at all time points. At 30 min after injury, the NSE level in
Discussion
Acute spinal cord injury is a common cause of mortality and morbidity. Many neuropathological, neuroendocrinological and neurobiological alterations happen during the acute phase of SCI.[5], [6], [7] Successful management of SCI necessitates an appropriate diagnostic standard for the acute phases after injury. Neurological examinations provide a general indication of spinal cord neurological function, but are unreliable, especially during the acute phase (first 24 h) after SCI as a result of
References (10)
- et al.
Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment
Exp Neurol
(1985) - et al.
Behavioral assessment of functional deficit in rats with contusive spinal cord injury
J Neurosci Methods
(1987) - et al.
Spinal cord contusion in the rat: production of graded, reproducible, injury groups
Exp Neurol
(1985) - et al.
Serum biomarkers for experimental actute spinal cord injury: rapid elevation of neuron-specific enolase and S-100β
Neurosurgery
(2005) - et al.
Peri-operative levels of s-100 protein in serum: markers for surgical manipulation and postoperative complicatin
Minim Invasive Neurosurg
(2003)
Cited by (60)
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
2023, Molecular Therapy OncolyticsIschemic Spinal Cord Injury—Experimental Evidence and Evolution of Protective Measures
2022, Annals of Thoracic SurgeryCitation Excerpt :The S100 calcium-binding protein-β is a glial-specific neurotrophic and neuroprotective protein that may indicate neuronal tissue damage in adults.30 Its elevation was demonstrated in acute traumatic SCI in animals and humans31,32 and in a number of clinical studies of patients undergoing aortic repair.33–35 Nevertheless, the protein, earlier considered to have a great diagnostic potential, is nowadays viewed with a degree of uncertainty: measuring its level in serum and CSF at the same time may be confusing, probably as a result of blood contamination from noncerebral tissues.36,37
S100b in spinal cord injury
2022, Diagnosis and Treatment of Spinal Cord InjuryNeurochemical biomarkers of acute spinal cord injury
2022, Neural Repair and Regeneration after Spinal Cord Injury and Spine TraumaAutoantibodies in central nervous system trauma: New frontiers for diagnosis and prognosis biomarkers
2020, Biomarkers for Traumatic Brain Injury